| scholarly article | Q13442814 |
| P356 | DOI | 10.3171/2011.4.JNS101172 |
| P698 | PubMed publication ID | 21663411 |
| P50 | author | Isaac Yang | Q39185000 |
| Tarik Tihan | Q92835489 | ||
| P2093 | author name string | Andrew T Parsa | |
| Seunggu J Han | |||
| Michael E Sughrue | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunology | Q101929 |
| glioblastoma | Q282142 | ||
| pilocytic astrocytoma | Q2095252 | ||
| P304 | page(s) | 505-511 | |
| P577 | publication date | 2011-06-10 | |
| P1433 | published in | Journal of Neurosurgery | Q15708886 |
| P1476 | title | Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology | |
| P478 | volume | 115 |
| Q47882427 | Analysis of immunobiologic markers in primary and recurrent glioblastoma |
| Q52720555 | Athymic mice reveal a requirement for T-cell-microglia interactions in establishing a microenvironment supportive of Nf1 low-grade glioma growth. |
| Q91670709 | CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy |
| Q47126472 | CD4+ and Perivascular Foxp3+ T Cells in Glioma Correlate with Angiogenesis and Tumor Progression |
| Q26740520 | CD8 T Cell-Independent Antitumor Response and Its Potential for Treatment of Malignant Gliomas |
| Q37308164 | Characterization of distinct immunophenotypes across pediatric brain tumor types |
| Q64267591 | Clinical chimeric antigen receptor-T cell therapy: a new and promising treatment modality for glioblastoma |
| Q50109459 | Current state and future prospects of immunotherapy for glioma |
| Q39381281 | Engineering challenges for brain tumor immunotherapy |
| Q55460610 | Eosinophil infiltrates in pilocytic astrocytomas of children and young adults. |
| Q64058805 | Ex vivo-expanded highly purified natural killer cells in combination with temozolomide induce antitumor effects in human glioblastoma cells in vitro |
| Q52366335 | Glioblastoma: new therapeutic strategies to address cellular and genomic complexity. |
| Q36457087 | Host response in tumor diagnosis and prognosis: importance of immunologists and pathologists alliance |
| Q37687506 | Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference |
| Q48395553 | Immune cell infiltrates in atypical teratoid/rhabdoid tumors |
| Q38907925 | Immune checkpoint inhibition and its relationship with hypermutation phenoytype as a potential treatment for Glioblastoma |
| Q47660305 | Immunophenotyping of pediatric brain tumors: correlating immune infiltrate with histology, mutational load, and survival and assessing clonal T cell response. |
| Q36485389 | Immunoprofiling for prognostic assessment of colon cancer: a novel complement to ultrastaging |
| Q36408364 | Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells |
| Q88746661 | Microfluidics in Malignant Glioma Research and Precision Medicine |
| Q90232798 | NT5E/CD73 as Correlative Factor of Patient Survival and Natural Killer Cell Infiltration in Glioblastoma |
| Q38148501 | Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumours |
| Q90137156 | Natural killer cells in the brain tumor microenvironment: Defining a new era in neuro-oncology |
| Q34457728 | Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth |
| Q41913561 | Perspectives on the immunologic microenvironment of astrocytomas |
| Q97528128 | Phase I study of vinblastine in combination with nilotinib in children, adolescents, and young adults with refractory or recurrent low-grade glioma |
| Q47967336 | Preliminary results of immune modulating antibody MDV9300 (pidilizumab) treatment in children with diffuse intrinsic pontine glioma |
| Q35815273 | Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma |
| Q47836415 | Recognition by natural killer cells of N6-isopentenyladenosine-treated human glioma cell lines |
| Q30855264 | Screening genes crucial for pediatric pilocytic astrocytoma using weighted gene coexpression network analysis combined with methylation data analysis |
| Q37496791 | Targeted STAT3 disruption in myeloid cells alters immunosuppressor cell abundance in a murine model of spontaneous medulloblastoma |
| Q38557236 | The Dynamics of Interactions Among Immune and Glioblastoma Cells |
| Q99238181 | The Role of NK Cells and Innate Lymphoid Cells in Brain Cancer |
| Q38211074 | The role of inflammation in brain cancer |
| Q36924298 | The role of microglia and macrophages in glioma maintenance and progression |
| Q39045958 | The role of the immune system in neurofibromatosis type 1-associated nervous system tumors |
| Q38726535 | Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM. |
| Q39413633 | VEGF receptor inhibitors block the ability of metronomically dosed cyclophosphamide to activate innate immunity-induced tumor regression. |
Search more.